HYCAMTIN
topotecan hydrochloride
- Strength
- 4 mg/4mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Topoisomerase Inhibitor
Novartis Pharmaceuticals Corporation
Not stocked by us — reference only
topotecan
Listed by Sandoz Inc
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Topoisomerase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 66758-102 |
| FDA application | NDA020981 |
| RxNorm concept | 747193 |
| Package sizes listed | 1 |
| Marketed since | February 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
topotecan hydrochloride
Novartis Pharmaceuticals Corporation
Not stocked by us — reference only
topotecan
Sandoz Inc
Not stocked by us — reference only
Accord Healthcare Inc.
Not stocked by us — reference only
Hospira, Inc.
Not stocked by us — reference only
Accord Healthcare, Inc.
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Actavis Pharma, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.